Patents by Inventor Michel Trudel

Michel Trudel has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 7220545
    Abstract: A polypeptide useful as an immunogen element and characterised in that it is carried on the peptide sequence between amino acid residues 130–230 of the G protein sequence of the human respiratory syncytial virus of sub-groups A and B, or of the bovine respiratory syncytial virus, or on a sequence at least 80% homologous thereto. An immunogenic agent or pharmaceutical composition containing said polypeptide, and a method for preparing same, are also disclosed.
    Type: Grant
    Filed: September 5, 2003
    Date of Patent: May 22, 2007
    Assignee: Pierre Fabre Medicament
    Inventors: Hans Binz, Thien Ngoc N′Guyen, Thierry Baussant, Michel Trudel
  • Publication number: 20050250933
    Abstract: A polypeptide useful as an immunogen element and characterised in that it is carried on the peptide sequence between amino acid residues 130-230 of the G protein sequence of the human respiratory syncytial virus of sub-groups A and B, or of the bovine respiratory syncytial virus, or on a sequence at least 80% homologous thereto. An immunogenic agent or pharmaceutical composition containing said polypeptide, and a method for preparing same, are also disclosed.
    Type: Application
    Filed: September 5, 2003
    Publication date: November 10, 2005
    Applicant: PIERRE FABRE MEDICAMENT
    Inventors: Hans Binz, Thien N'Guyen, Thierry Baussant, Michel Trudel
  • Patent number: 6616930
    Abstract: A polypeptide useful as an immunogen element and characterized in that it is carried on the peptide sequence between amino acid residues 130-230 of the G protein sequence of the human respiratory syncytial virus of sub-groups A and B, or of the bovine respiratory syncytial virus, or on a sequence at least 80% homologous thereto. An immunogenic agent or pharmaceutical composition containing said polypeptide, and methods for preparing and using the same, are also disclosed.
    Type: Grant
    Filed: March 5, 2002
    Date of Patent: September 9, 2003
    Assignee: Pierre Fabre Medicament
    Inventors: Hans Binz, Thien Ngoc N'Guyen, Thierry Baussant, Michel Trudel
  • Publication number: 20030064078
    Abstract: A polypeptide useful as an immunogen element and characterised in that it is carried on the peptide sequence between amino acid residues 130-230 of the G protein sequence of the human respiratory syncytial virus of sub-groups A and B, or of the bovine respiratory syncytial virus, or on a sequence at least 80% homologous thereto. An immunogenic agent or pharmaceutical composition containing said polypeptide, and a method for preparing same, are also disclosed.
    Type: Application
    Filed: March 5, 2002
    Publication date: April 3, 2003
    Applicant: PIERRE FABRE MEDICAMENT
    Inventors: Hans Binz, Thien Ngoc N'Guyen, Thierry Baussant, Michel Trudel
  • Patent number: 6537556
    Abstract: A polypeptide useful as an immunogen element and characterized in that it is carried on the peptide sequence between amino acid residues 130-230 of the G protein sequence of the human respiratory syncytial virus of sub-groups A and B, or of the bovine respiratory syncytial virus, or on a sequence at least 80% homologous thereto. An immunogenic agent or pharmaceutical composition containing said polypeptide, and methods for preparing and using the same, are also disclosed.
    Type: Grant
    Filed: June 30, 2000
    Date of Patent: March 25, 2003
    Assignee: Pierre Fabre Medicament
    Inventors: Hans Binz, Thien N'Guyen Ngoc, Thierry Baussant, Michel Trudel
  • Patent number: 6410030
    Abstract: A polypeptide useful as an immunogen element and characterized in that it is carried on the peptide sequence between amino acid residues 130-230 of the G protein sequence of the human respiratory syncytial virus of sub-groups A and B, or of the bovine respiratory syncytial virus, or on a sequence at least 80% homologous thereto. An immunogenic agent or pharmaceutical composition containing said polypeptide, and methods for preparing and using the same, are also disclosed.
    Type: Grant
    Filed: September 1, 2000
    Date of Patent: June 25, 2002
    Assignee: Pierre Fabre Medicament
    Inventors: Hans Binz, Ngoc Thien N'Guyen, Thierry Baussant, Michel Trudel
  • Patent number: 6113911
    Abstract: A polypeptide useful as an immunogen element and characterized in that it is carried on the peptide sequence between amino acid residues 130-230 of the G protein sequence of the human respiratory syncytial virus of sub-groups A and B, or of the bovine respiratory syncytial virus, or on a sequence at least 80% homologous thereto. An immunogenic agent or pharmaceutical composition containing said polypeptide, and methods for preparing and using the same, are also disclosed.
    Type: Grant
    Filed: October 4, 1996
    Date of Patent: September 5, 2000
    Assignee: Pierre Fabre Medicament
    Inventors: Hans Binz, Thien N'Guyen Ngoc, Thierry Baussant, Michel Trudel